Pharma and Healthcare mutual fund

Mon, 18 May 2026 00:00:00 +0000

A Pharma and Healthcare mutual fund is a thematic equity scheme that invests at least 80 per cent of its corpus in pharmaceutical, healthcare, and life-sciences companies. The category sits within the SEBI sectoral and thematic framework. Pharma/healthcare is a popular thematic category among Indian retail investors, reflecting India’s position as a global pharma hub and the defensive characteristics of healthcare equity.

For Indian retail investors, pharma/healthcare mutual funds offer:

Defensive equity exposure: Less cyclical than industrials, banking.
Export-oriented growth: Indian pharma’s global export footprint.
Demographic tailwind: Aging populations driving healthcare demand.
Sectoral diversification: Pharma manufacturers + hospitals + diagnostics + medtech.

Major pharma/healthcare funds

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D.) Fund.
SBI Healthcare Opportunities Fund.
Nippon India Pharma Fund.
DSP Healthcare Fund.
Aditya Birla Sun Life Pharma and Healthcare Fund.
Mirae Asset Healthcare Fund.
Tata India Pharma and Healthcare Fund.

Investment universe

Pharma/healthcare funds invest across:

NIFTY Pharma TRI

Tue, 12 May 2026 00:00:00 +0000

The NIFTY Pharma Total Returns Index (NIFTY Pharma TRI) is the dividend-reinvested variant of the NIFTY Pharma index, maintained by NSE Indices Limited. The index covers the 20 largest and most liquid pharmaceutical and healthcare-related companies listed on the National Stock Exchange of India (NSE) . India is the world’s third-largest pharmaceutical producer by volume and the largest supplier of generic medicines globally; the NIFTY Pharma index reflects this industry’s representation in the Indian equity market. The TRI variant is used as the performance benchmark for pharmaceutical and healthcare sector mutual fund schemes and ETFs.

Healthcare on WebNotes

Pharma and Healthcare mutual fund

Major pharma/healthcare funds

Investment universe

NIFTY Pharma TRI